Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ishizuka JJ"'
Autor:
Lee DY; Department of Internal Medicine (Oncology), Smilow Cancer Center at Yale New Haven Hospital, New Haven, Connecticut, USA., McNamara M; Department of Internal Medicine (Oncology), Smilow Cancer Center at Yale New Haven Hospital, New Haven, Connecticut, USA., Yang A; Department of Internal Medicine (Oncology), Smilow Cancer Center at Yale New Haven Hospital, New Haven, Connecticut, USA., Yaskolko M; Department of Internal Medicine (Oncology), Smilow Cancer Center at Yale New Haven Hospital, New Haven, Connecticut, USA.; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA., Kluger H; Department of Internal Medicine (Oncology), Smilow Cancer Center at Yale New Haven Hospital, New Haven, Connecticut, USA., Tran T; Department of Internal Medicine (Oncology), Smilow Cancer Center at Yale New Haven Hospital, New Haven, Connecticut, USA., Olino K; Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA., Clune J; Department of Plastic and Reconstructive Surgery, Yale School of Medicine, New Haven, Connecticut, USA., Sznol M; Department of Internal Medicine (Oncology), Smilow Cancer Center at Yale New Haven Hospital, New Haven, Connecticut, USA., Ishizuka JJ; Department of Internal Medicine (Oncology), Smilow Cancer Center at Yale New Haven Hospital, New Haven, Connecticut, USA.; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA.; Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
Publikováno v:
Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2024 Jul 28. Date of Electronic Publication: 2024 Jul 28.
Autor:
Frey AE; Department of Surgery, Yale University School of Medicine, New Haven, CT, United States., Kerekes DM; Department of Surgery, Yale University School of Medicine, New Haven, CT, United States., Khan SA; Department of Surgery, Yale University School of Medicine, New Haven, CT, United States., Tran TT; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, United States., Kluger HM; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, United States., Clune JE; Department of Surgery, Yale University School of Medicine, New Haven, CT, United States., Ariyan S; Department of Surgery, Yale University School of Medicine, New Haven, CT, United States., Sznol M; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, United States., Ishizuka JJ; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, United States., Olino KL; Department of Surgery, Yale University School of Medicine, New Haven, CT, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Feb 06; Vol. 14, pp. 1336441. Date of Electronic Publication: 2024 Feb 06 (Print Publication: 2024).
Autor:
Dong M; Interdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA.; Department of Pathology, Yale School of Medicine, New Haven, CT, USA., Wang B; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA.; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Wei J; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.; Department of Internal Medicine (Oncology), Yale School of Medicine, New Haven, CT, USA., de O Fonseca AH; Interdepartmental Neuroscience Program, Yale School of Medicine, New Haven, CT, USA., Perry CJ; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.; Department of Internal Medicine (Oncology), Yale School of Medicine, New Haven, CT, USA., Frey A; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.; Department of Internal Medicine (Oncology), Yale School of Medicine, New Haven, CT, USA.; Department of Surgery, Yale School of Medicine, New Haven, CT, USA., Ouerghi F; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.; Department of Internal Medicine (Oncology), Yale School of Medicine, New Haven, CT, USA., Foxman EF; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA. ellen.foxman@yale.edu.; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA. ellen.foxman@yale.edu., Ishizuka JJ; Department of Pathology, Yale School of Medicine, New Haven, CT, USA. jeffrey.ishizuka@yale.edu.; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA. jeffrey.ishizuka@yale.edu.; Department of Internal Medicine (Oncology), Yale School of Medicine, New Haven, CT, USA. jeffrey.ishizuka@yale.edu., Dhodapkar RM; Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. rahul.dhodapkar@med.usc.edu., van Dijk D; Interdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA. david.vandijk@yale.edu.; Department of Internal Medicine (Cardiology), Yale School of Medicine, New Haven, CT, USA. david.vandijk@yale.edu.; Department of Computer Science, Yale University, New Haven, CT, USA. david.vandijk@yale.edu.
Publikováno v:
Nature methods [Nat Methods] 2023 Nov; Vol. 20 (11), pp. 1769-1779. Date of Electronic Publication: 2023 Nov 02.
Autor:
Horowitch B; Department of Internal Medicine (Oncology), Yale Cancer Center and Yale School of Medicine, New Haven, Connecticut.; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut., Lee DY; Department of Internal Medicine (Oncology), Yale Cancer Center and Yale School of Medicine, New Haven, Connecticut.; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut.; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Ding M; Department of Internal Medicine (Oncology), Yale Cancer Center and Yale School of Medicine, New Haven, Connecticut.; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut., Martinez-Morilla S; Department of Pathology, Yale School of Medicine, New Haven, Connecticut., Aung TN; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut., Ouerghi F; Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, California., Wang X; Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut., Wei W; Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut., Damsky W; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., Sznol M; Department of Internal Medicine (Oncology), Yale Cancer Center and Yale School of Medicine, New Haven, Connecticut., Kluger H; Department of Internal Medicine (Oncology), Yale Cancer Center and Yale School of Medicine, New Haven, Connecticut., Rimm DL; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut., Ishizuka JJ; Department of Internal Medicine (Oncology), Yale Cancer Center and Yale School of Medicine, New Haven, Connecticut.; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Aug 01; Vol. 29 (15), pp. 2908-2918.
Autor:
Collins NB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, Boston, Massachusetts, USA., Al Abosy R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Miller BC; Lineberger Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Bi K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Zhao Q; Oncology Discovery Biology, Bristol Myers Squibb, Lawrenceville, New Jersey, USA., Quigley M; Research Biology, Gilead Sciences Inc, Foster City, California, USA., Ishizuka JJ; Department of Internal Medicine (Oncology), Yale Cancer Center and Yale School of Medicine, New Haven, New Jersey, USA., Yates KB; Broad Institute, Cambridge, Massachusetts, USA.; Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA., Pope HW; Arsenal Biosciences, San Francisco, California, USA., Manguso RT; Broad Institute, Cambridge, Massachusetts, USA.; Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA., Shrestha Y; AstraZeneca, Gaithersburg, Maryland, USA., Wadsworth M; Broad Institute, Cambridge, Massachusetts, USA.; Institute for Medical Engineering & Science (IMES), Department of Chemistry and Koch Institute for Integrative Cancer Research, Ragon Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA., Hughes T; Broad Institute, Cambridge, Massachusetts, USA.; Institute for Medical Engineering & Science (IMES), Department of Chemistry and Koch Institute for Integrative Cancer Research, Ragon Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA., Shalek AK; Broad Institute, Cambridge, Massachusetts, USA.; Institute for Medical Engineering & Science (IMES), Department of Chemistry and Koch Institute for Integrative Cancer Research, Ragon Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA., Boehm JS; Broad Institute, Cambridge, Massachusetts, USA., Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute, Cambridge, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Doench JG; Broad Institute, Cambridge, Massachusetts, USA., Haining WN; Arsenal Biosciences, San Francisco, California, USA nhaining@arsenalbio.com.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Mar; Vol. 10 (3).
Autor:
Wei J; Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, CT, USA; Department of Internal Medicine (Oncology), Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Ishizuka JJ; Department of Internal Medicine (Oncology), Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. Electronic address: jeffrey.ishizuka@yale.edu.
Publikováno v:
Immunity [Immunity] 2021 Aug 10; Vol. 54 (8), pp. 1630-1632.
Autor:
Griffin GK; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Wu J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Iracheta-Vellve A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Patti JC; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hsu J; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Davis T; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Dele-Oni D; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Du PP; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Halawi AG; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ishizuka JJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Internal Medicine (Oncology), Yale Cancer Center and Yale School of Medicine, New Haven, CT, USA., Kim SY; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Klaeger S; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Knudsen NH; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Miller BC; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Immunology and Evergrande Center for Immunological Diseases, Harvard Medical School, Boston, MA, USA., Nguyen TH; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Olander KE; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Papanastasiou M; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Rachimi S; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Robitschek EJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Schneider EM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Yeary MD; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Zimmer MD; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Jaffe JD; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Inzen Therapeutics, Cambridge, MA, USA., Carr SA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Doench JG; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Haining WN; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Merck, Boston, MA, USA., Yates KB; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Manguso RT; Broad Institute of MIT and Harvard, Cambridge, MA, USA. rmanguso@mgh.harvard.edu.; Department of Medicine and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. rmanguso@mgh.harvard.edu., Bernstein BE; Broad Institute of MIT and Harvard, Cambridge, MA, USA. bernstein.bradley@mgh.harvard.edu.; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. bernstein.bradley@mgh.harvard.edu.
Publikováno v:
Nature [Nature] 2021 Jul; Vol. 595 (7866), pp. 309-314. Date of Electronic Publication: 2021 May 05.
Autor:
Wu Z; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Zhou J; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Zhang X; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Zhang Z; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Xie Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Liu JB; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ho ZV; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Panda A; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Committee on Immunology, The University of Chicago, Chicago, IL, USA., Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Cañadas I; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Akarca FG; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., McFarland JM; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Nagaraja AK; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Goss LB; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Kesten N; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Si L; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Lim K; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Liu Y; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Zhang Y; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Baek JY; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Liu Y; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Patil DT; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Katz JP; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Hai J; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Bao C; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Stachler M; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Qi J; Cancer Biology Department, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ishizuka JJ; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Nakagawa H; Herbert Irving Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, NY, USA., Rustgi AK; Herbert Irving Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, NY, USA., Wong KK; Division of Hematology and Medical Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA., Meyerson M; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Barbie DA; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Brown M; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Long H; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Bass AJ; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. ab5147@cumc.columbia.edu.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA. ab5147@cumc.columbia.edu.; Herbert Irving Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, Columbia University, New York, NY, USA. ab5147@cumc.columbia.edu.
Publikováno v:
Nature genetics [Nat Genet] 2021 Jun; Vol. 53 (6), pp. 881-894. Date of Electronic Publication: 2021 May 10.
Autor:
Griffin GK; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Weirather JL; Department of Data Sciences and., Roemer MGM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Lipschitz M; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Kelley A; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Chen PH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Gusenleitner D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Jeter E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Pak C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Gjini E; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Chapuy B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology and Oncology, University Medical Center, Göttingen, Germany., Rosenthal MH; Department of Imaging, Dana-Farber Cancer Institute, Boston, MA., Xu J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Chen BJ; Department of Pathology, UMass Memorial Medical Center, Worcester, MA., Sohani AR; Department of Pathology and., Lovitch SB; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Abramson JS; Center for Lymphoma, Massachusetts General Hospital, Boston, MA; and., Ishizuka JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medical Oncology, Yale Cancer Center, New Haven, CT., Kim AI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fletcher CD; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Neuberg D; Department of Data Sciences and., Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Wright K; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Ligon AH; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
Publikováno v:
Blood [Blood] 2021 Mar 11; Vol. 137 (10), pp. 1353-1364.
Autor:
Miller BC; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Sen DR; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Al Abosy R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bi K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Virkud YV; Division of Pediatric Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA., LaFleur MW; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Yates KB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lako A; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Felt K; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Naik GS; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Manos M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gjini E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kuchroo JR; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Ishizuka JJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Collier JL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Griffin GK; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Maleri S; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Comstock DE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Weiss SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Brown FD; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Panda A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Zimmer MD; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Manguso RT; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rodig SJ; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Sharpe AH; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA., Haining WN; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. wnhaining@gmail.com.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. wnhaining@gmail.com.; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA. wnhaining@gmail.com.
Publikováno v:
Nature immunology [Nat Immunol] 2019 Nov; Vol. 20 (11), pp. 1556.